Trials / Sponsors / NovaRx Corporation
NovaRx Corporation
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemoth Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB | Phase 3 | 2008-07-01 |
| Completed | Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer Lung Neoplasm, Carcinoma, Bronchogenic | Phase 2 | 2003-03-01 |
| No Longer Available | Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L) Non-small Cell Lung Cancer | — | — |